Effect of synbiotic supplementation on azotemia of patient with chronic kidney disease
Not Applicable
- Conditions
- Chronic kidney disease.Chronic kidney disease
- Registration Number
- IRCT2013062413756N1
- Lead Sponsor
- Vice chancellor for research,Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Inclusion criteria included: age 65-30 years; chronic kidney disease stage 3 or 4 (GFR = 15-59ml/min/1.73m2). Exclusion criteria included: pregnant women; Lactulose or antibiotic consumption within 14 days before study; active addiction to alcohol; hepatitis, HIV and HIV infection and criteria for sample loss include: Lactulose or antibiotics consumption during the study and starting hemodialysis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BUN. Timepoint: before and at the end of intervention. Method of measurement: In term of milligrams per deciliter and through blood test.;Blood Creatinine. Timepoint: before and at the end of intervention. Method of measurement: in terms of milligrams per deciliter and through blood test.;Uric acid. Timepoint: before and at the end of intervention. Method of measurement: in terrms of milligrams per deciliter and through blood test.;Creatinine clearance. Timepoint: before and at the end of intervention. Method of measurement: in terms of Milli liter per minute per 1.73 square meters and through blood and urine tests.;GFR. Timepoint: before and at the end of intervention. Method of measurement: in terms of milli liter per minute.
- Secondary Outcome Measures
Name Time Method ipid profile include TG,Cholesterol,LDL,HDL. Timepoint: before and at the end of intervention. Method of measurement: In terms of milligrams per deciliter and through blood test.